Langer will work with the company to develop its portfolio of cannabidiol candidates for bone health.
Kalytera Therapeutics announced on June 23, 2016 that it has appointed Robert S. Langer to the company’s Scientific advisory board. Kalytera is a California-based pharmaceutical company working to develop a portfolio of non-psychoactive cannabinoid and endocannabinoid medicines.
Langer is a David H. Koch Institute Professor at the Massachusetts Institute of Technology who has received more than 220 awards for his contributions to the drug delivery and tissue engineering fields. Langer will work with Kalytera to advance the company’s portfolio of candidates for bone health.
“Transdermal delivery of cannabidiol, and other proprietary cannabinoids, may confer a variety of benefits to patients,” Langer said in a press announcement. “I look forward to working with Kalytera’s leadership to evaluate and optimally advance the company’s portfolio of drug candidates for bone health.”
Kalytera currently has four drug candidates in its pipeline, including treatments for osteoporosis, bone healing, Prader-Willi Syndrome, and obesity. The company also recently entered into a technology licensing agreement with Delivra Corporation for transdermal technologies for the delivery of cannabidiol, KAL436/439, and KAL671.
Source: Kalytera
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.